
pital revenue was EUR 62.5 million in 2021 and EUR 59.4 million
in 2020. Established in 2013, Pohjola Hospital is a hospital chain
specialising in orthopedics, i.e. a treatment of musculoskeletal dis-
orders and accidents. Pohjola Hospital operates in five university
hospital cities: Helsinki, Tampere, Turku, Oulu and Kuopio.
The company had an average of 295 employees and over 300
practitioners in 2021.
The proposals of Pihlajalinna Plc’s Shareholders’ Nomina-
tion Board to the Annual General Meeting 2022
The number of members and composition of the Board of Directors
The Nomination Board proposes to the Annual General Meeting
of Pihlajalinna Plc, scheduled to be held on 13 April 2022, that the
number of the members of the Board be confirmed to be seven
instead of the current six. The Nomination Board proposes that
Hannu Juvonen, Mika Manninen, Leena Niemistö, Kati Sulin, Seija
Turunen and Mikko Wirén, currently members of the Board of
Directors, be re-elected as members of the Board of Directors. The
Nomination Board proposes that Heli Iisakka be elected as a new
member of the Board of Directors. Heli Iisakka, born 1968, M.Sc.
(Econ.), is the CFO of Colliers Finland Oy. Iisakka is independent of
the company and its major shareholders.
With regard to the procedure for the election of the members of
the Board of Directors, the Shareholders’ Nomination Board rec-
ommends that the shareholders vote on the proposal as a whole
at the Annual General Meeting. The Nomination Board proposes
that the Annual General Meeting elect Mikko Wirén as the Chair-
man of the Board and Leena Niemistö as the Vice-Chairman.
The Shareholders’ Nomination Board proposes that, due to the
ongoing significant changes in the social services and healthcare
sector and the company’s significant ongoing strategic develop-
ment, the role of the Chairman of the Board of Directors should
still be a full-time role for the next term of oce. The Nomination
Board’s shared will is that, after this term, the role of the Chairman
of the Board of Directors will no longer be a full-time role.
Remuneration of the members of the Board of Directors
The Shareholders’ Nomination Board proposes that the remunera-
tion of the Chairman of the Board of Directors be kept unchanged,
and that the remuneration of the Vice-Chairman, the Chairman of
the Audit Committee and the members of the Board of Direc-
Scope of operations 2021
2020
restated ** 2019 2018
2017
without
IFRS 16
Revenue, EUR million 577,8 508,7 518,6 487,8 424,0
Change, % 13,6 -1,9 6,3 15,0 6,2
* Organic revenue growth, EUR million 58,1 -11,3 13,4 -2,0 10,1
Change, % 11,4 -2,2 2,8 -0,5 2,5
* Gross investments, EUR million 44,8 25,4 44,1 160,0 30,4
% of revenue 7,8 5,0 8,5 32,8 7,2
* Capitalised development costs, EUR million 0,0 0,4 0,5 1,3 1,2
% of revenue 0,0 0,1 0,1 0,3 0,3
Employee benefit expenses, EUR million 255,2 214,2 222,0 208,4 175,4
Personnel at the end of the period (NOE) 6 297 5 550 5 815 5 850 4 753
Average number of personnel (FTE) 4 746 4 308 4 515 4 618 3 879
Profitability
* EBITDA, EUR million 62,6 52,2 47,8 44,8 33,3
* EBITDA, % 10,8 10,3 9,2 9,2 7,9
* Adjusted EBITDA, EUR million 65,3 54,8 55,7 45,9 34,4
* Adjusted EBITDA, % 11,3 10,8 10,7 9,4 8,1
* Operating profit (EBIT), EUR million 27,9 18,1 10,2 13,2 19,1
* Operating profit, % 4,8 3,6 2,0 2,7 4,5
* Adjusted operating profit (EBIT), EUR million 30,3 20,9 21,4 14,4 16,9
* Adjusted operating profit, % 5,3 4,1 4,1 3,0 4,0
* Adjusted operating profit before the amor-
tisation and impairment of intangible assets
(EBITA), EUR million
37,3 27,4 28,9 19,6 23,8
* Adjusted EBITA, % 6,5 5,4 5,6 4,0 5,6
Net financial expenses, EUR million -3,7 -4,4 -3,9 -3,8 -1,7
% of revenue -0,6 -0,9 -0,8 -0,8 -0,4
* Profit before tax, EUR million 24,2 13,7 6,3 9,5 17,4
% of revenue 4,2 2,7 1,2 1,9 4,1
Income tax, EUR million -5,1 -4,8 -1,8 -2,7 -3,4
Profit for the period 19,1 8,9 4,5 6,8 14,1
Cash flow after investments, EUR million 24,9 42,8 17,4 -18,8 -25,1
* Return on equity (ROE), % 16,1 8,1 3,8 5,7 13,6
* Return on capital employed (ROCE), % 8,8 5,7 3,1 4,7 11,8
Key financial figures
45
BUSINESS AND STRATEGY | SUSTAINABILITY | REPORT BY THE BOARD OF DIRECTORS | AUDITED FINANCIAL STATEMENTS